Show simple item record

FieldValueLanguage
dc.contributor.authorGrundy, Q
dc.contributor.authorHabibi, R
dc.contributor.authorShnier, A
dc.contributor.authorMayes, C
dc.contributor.authorLipworth, W
dc.date.accessioned2018-06-05
dc.date.available2018-06-05
dc.date.issued2018-01-01
dc.identifier.citationGrundy Q, Habibi R, Shnier A, Mayes C, Lipworth W. Decoding disclosure: Comparing conflict of interest policy among the United States, France, and Australia. Health Policy. In Press. Published online 21/3/2018 [Made open access by the European Observatory on Health Systems and Policies]en
dc.identifier.urihttp://hdl.handle.net/2123/18320
dc.description.abstract“Sunshine” policy, aimed at making financial ties between health professionals and industry publicly transparent, has recently gone global. Given that transparency is not the sole means of managing conflict of interest, and is unlikely to be effective on its own, it is important to understand why disclosure has emerged as a predominant public policy solution, and what the effects of this focus on transparency might be. We used Carol Bacchi’s problem-questioning approach to policy analysis to compare the Sunshine policies in three different jurisdictions, the United States, France and Australia. We found that transparency had emerged as a solution to several different problems including misuse of tax dollars, patient safety and public trust. Despite these differences in the origins of disclosure policies, all were underpinned by the questionable assumption that informed consumers could address conflicts of interest. We conclude that, while transparency reports have provided an unprecedented opportunity to understand the reach of industry within healthcare, policymakers should build upon these insights and begin to develop policy solutions that address systemic commercial influence.en
dc.language.isoenen
dc.publisherElsevieren
dc.relationNHMRC Career Development Fellowship (APP1036539) NHMRC Project Grant (APP1059732)en
dc.rightsOther
dc.subjectDisclosureen
dc.subjectConflict of interesten
dc.subjectPharmaceutical industryen
dc.subjectTransparencyen
dc.subjectComparative analysisen
dc.titleDecoding disclosure: Comparing conflict of interest policy among the United States, France, and Australia.en
dc.typeArticleen
dc.subject.asrc2201 Applied ethicsen
dc.subject.asrc1117 Public Health and Health Sciencesen
dc.identifier.doi10.1016/j.healthpol.2018.03.015en
dc.type.pubtypePost-printen
usyd.facultyFaculty of Medicine and Health, Sydney Health Ethics


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.